Pancreatic Cancer Research

ResearcherAbramson Cancer CenterActive in the last 2 years

Mark Alan Rosen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1581-0220; OpenAlex author ID A5109033239, A5111808513; NIH RePORTER profile ID 8645575. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
1
Labs led
0
Collaborators
17
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper, 1 grant · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 8

  1. Co-Clinical Evaluation of Synthetic Vitamin D and Chemotherapy in Pancreatic Cancer by Integrated Imaging and Molecular Analyses. Co-author DOI 10.1158/2767-9764.crc-26-0443↗
  2. Multimetric MRI Captures Early Response and Acquired Resistance of Pancreatic Cancer to KRAS Inhibitor Therapy. Co-author DOI 10.1158/1078-0432.ccr-24-4049↗
  3. Effect of Stroma-directed Drugs in Combination with Chemotherapy Against Pancreatic Cancer- a Preclinical Study Co-author DOI 10.1101/2024.12.24.630138↗
  4. Impact of Arterial Input Function and Pharmacokinetic Models on DCE-MRI Biomarkers for Detection of Vascular Effect Induced by Stroma-Directed Drug in an Ortho… Co-author DOI 10.1007/s11307-023-01824-7↗
  5. DWI Metrics Differentiating Benign Intraductal Papillary Mucinous Neoplasms from Invasive Pancreatic Cancer: A Study in GEM Models. Co-author DOI 10.3390/cancers14164017↗
  6. Respiratory Motion Mitigation and Repeatability of Two Diffusion-Weighted MRI Methods Applied to a Murine Model of Spontaneous Pancreatic Cancer. Co-author DOI 10.3390/tomography7010007↗
  7. Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation. Co-author DOI 10.1038/s41416-019-0582-7↗
  8. Dynamic Contrast-enhanced MRI Detects Responses to Stroma-directed Therapy in Mouse Models of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-18-2276↗

Grants 1

  1. Penn Quantitative MRI Resource for Pancreatic Cancer U24CA231858↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rong Zhou · 7 shared papers, 1 shared grant, 2019–2026 · strength 1.79
  2. Peter James O'Dwyer · 5 shared papers, 1 shared grant, 2019–2026 · strength 1.27
  3. Stephen Pickup · 7 shared papers, 2019–2026 · strength 1.26
  4. Mamta Gupta · 4 shared papers, 2022–2026 · strength 0.77
  5. Jianbo Cao · 4 shared papers, 2019–2023 · strength 0.62
  6. Thomas Benjamin Karasic · 3 shared papers, 2022–2026 · strength 0.54
  7. Samantha B. Kemp · 1 shared paper, 2025 · strength 0.23
  8. Margo Orlen · 1 shared paper, 2025 · strength 0.23
  9. Ben Z. Stanger · 1 shared paper, 2025 · strength 0.23
  10. Fang Liu · 1 shared paper, 2024 · strength 0.18
  11. Miguel Romanello Joaquim · 1 shared paper, 2022 · strength 0.12
  12. Max Miller Wattenberg · 1 shared paper, 2020 · strength 0.11
  13. Susan M. Domchek · 1 shared paper, 2020 · strength 0.11
  14. Katherine L. Nathanson · 1 shared paper, 2020 · strength 0.11
  15. Shun Yu · 1 shared paper, 2020 · strength 0.11
  16. Gregory Lawrence Beatty · 1 shared paper, 2020 · strength 0.11
  17. Kim A. Reiss · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.